The Effect of Acupressure on Procedural Pain, Anxiety and Hemodynamic Variables During Chest Tube Removal
NCT ID: NCT05875337
Last Updated: 2025-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2023-05-25
2024-05-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Acupressure Applied Before Cystectomy on Preoperative Anxiety Level
NCT05325307
The Effect of Post-Cesarean Section Acupressure on the Severity of Pain and First Mobilization Distance
NCT05311449
Non-Pharmacological Method to Relieve Back Pain
NCT05893355
The Effects of Acupressure on Pain After Cesarean Section
NCT04337801
The Effect of Acupressure on Preoperative Anxiety and Postoperative Pain and Nausea-Vomiting
NCT06040411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
When acupressure/plesebo acupressure application is completed, the chest tube will be removed by the physician. Procedural pain level, anxiety level and hemodynamic variables of all patients in the acupressure and placebo acupressure groups will be re-evaluated immediately and 15 minutes after removal of the chest tube.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupressure Group (experimental)
In the acupressure groups the points are LI4, LI11 and HT7.
Acupressure
Before starting the acupressure point application, the area around the area where the pressure will be applied for 20-30 seconds will be gently rubbed with the palm of the hand. By gently rubbing the surrounding tissue, tension and tissue sensitivity will be reduced and the tissue will be relaxed by heating, relaxing and preparing the point area. Pressure will be applied to the determined points (LI4, LI11 and HT7) with the thumb, index or middle finger manually for 5 seconds to create a depth of 1-1.5 cm and rest for 2 seconds. Each point will be applied for 2 minutes and the application will last 12 minutes.
Placebo Acupressure Group (control)
In the placebo acupressure group the points are 1.5 cm away from LI4, LI11 and HT7 points.
Placebo acupressure
Before starting the application to the placebo acupressure point, the area around the area where pressure will be applied for 20-30 seconds will be gently rubbed with the palm of the hand. By gently rubbing the surrounding tissue, tension and tissue sensitivity will be reduced and the tissue will be relaxed by heating, relaxing and preparing the point area. Light pressure will be applied to the determined points (1.5 cm away from LI4, LI11 and HT7 points) with the thumb, index or middle finger. Each point will be applied for 2 minutes and the application will last 12 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupressure
Before starting the acupressure point application, the area around the area where the pressure will be applied for 20-30 seconds will be gently rubbed with the palm of the hand. By gently rubbing the surrounding tissue, tension and tissue sensitivity will be reduced and the tissue will be relaxed by heating, relaxing and preparing the point area. Pressure will be applied to the determined points (LI4, LI11 and HT7) with the thumb, index or middle finger manually for 5 seconds to create a depth of 1-1.5 cm and rest for 2 seconds. Each point will be applied for 2 minutes and the application will last 12 minutes.
Placebo acupressure
Before starting the application to the placebo acupressure point, the area around the area where pressure will be applied for 20-30 seconds will be gently rubbed with the palm of the hand. By gently rubbing the surrounding tissue, tension and tissue sensitivity will be reduced and the tissue will be relaxed by heating, relaxing and preparing the point area. Light pressure will be applied to the determined points (1.5 cm away from LI4, LI11 and HT7 points) with the thumb, index or middle finger. Each point will be applied for 2 minutes and the application will last 12 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older,
* Conscious and cooperative,
* Speaks and understands Turkish,
* General condition and hemodynamic variables are stable,
* Planned surgical intervention,
* No previous chest tube experience,
* Acupressure/placebo acupressure without scars, scars, tenderness in the area to be acupressure,
* No active COVID-19 infection,
* Does not have any psychiatric diagnosis,
* Not using psychiatric and/or local neuromuscular blocking drugs,
* Patients who agreed to participate in the study (signed the Informed Consent Form)
Exclusion Criteria
* Under 18 years of age,
* Conscious and uncooperative,
* Speaking Turkish but not understanding it,
* Unstable general condition and hemodynamic variables,
* Underwent emergency surgical intervention,
* Anyone with previous chest tube experience,
* Wounds, scars, tenderness in the area where acupressure/placebo acupressure will be applied,
* With active COVID-19 infection,
* Has an existing psychiatric diagnosis,
* Psychiatric and/or local neuromuscular blocking drugs,
* Patients who did not agree to participate in the study (did not sign the Informed Consent Form).
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mersin University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tugba CAM YANIK
Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gülay ALTUN UĞRAŞ, PhD
Role: STUDY_DIRECTOR
Mersin University
Serpil YÜKSEL, PhD
Role: PRINCIPAL_INVESTIGATOR
Necmettin Erbakan University
Didem KANDEMİR, PhD
Role: PRINCIPAL_INVESTIGATOR
England
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mersin University Hospital
Mersin, Yenişehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MersinU.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.